Golden State Warriors star Steph Curry has accepted the role of assistant general manager for the basketball programs at alma mater Davidson College. Curry, a four-time NBA champion with the ...

Madrigal Pharmaceuticals, Inc.'s Rezdiffra had a strong launch with $103.3M in Q4 sales and solid liquidity, but GLP-1 competition from Novo and Lilly poses significant future challenges. Madrigal ...

PORT ST. LUCIE, Fla. -- New York Mets infielder Nick Madrigal could miss the entire 2025 season with a fractured left shoulder. Manager Carlos Mendoza told reporters Friday that Madrigal needs ...

New York Mets utility infielder Nick Madrigal will soon undergo shoulder surgery and likely miss the entirety of the upcoming 2025 season, manager Carlos Mendoza told reporters on Friday.

Copyright 2025 The Associated Press. All Rights Reserved. New York Mets’ Nick Madrigal puts on batting gloves during a spring training baseball practice Monday, Feb ...

Mets manager Carlos Mendoza informed reporters, including Anthony DiComo of MLB.com, that infielder Nick Madrigal will require surgery on his fractured left shoulder. The recovery from that ...

The New York Mets have lost an important depth piece, Nick Madrigal, who is expected to miss the entire 2025 season. As manager Carlos Mendoza shared with reporters on Friday, the utility ...

“Alma’s Way,” the Emmy-nominated animated series from Fred Rogers Productions, has been renewed for a third season at PBS Kids. The new season will feature 15 half-hour episodes, including a ...

With sales of $103 million in the fourth quarter and $180 million in its first nine months on the market, Madrigal Pharmaceuticals’ metabolic dysfunction-associated steatohepatitis (MASH ...

B. Riley upgraded Madrigal Pharmaceuticals (MDGL) to Buy from Neutral with a price target of $422, up from $236. The firm notes the erosion of three key pillars to the prior cautious outlook ...

Good day, and thank you for standing by. Welcome to Madrigal Pharmaceuticals' Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in listen-only mode.

Madrigal posted a Q4 loss of $2.71 per share, beating estimates, with sales of $103.22 million surpassing the $98.56 million consensus. How to Spot the Market Bottom: Matt Maley has navigated ...